ADMA Biologics repays $30M of senior secured term loan, total debt reduced to $75M

ADMA BIOLOGICS, INC.

Repaid $30M of original $62.5M term loan with Ares Capital using cash on hand.
Total gross debt now $75M: $42.5M revolver plus $32.5M term loan outstanding.
This is second paydown in four months; total gross debt reduced by 29%.
Lowered interest expense expected to enhance near-term earnings growth potential.
CEO cites confidence in sustained earnings growth and ongoing cash generation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.